Obalon Therapeutics, Inc.
OBLN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5,707 | $4,123 | $2,515 | $693 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $23 | $775 | $734 | $987 |
| Inventory | $0 | $2,552 | $2,532 | $2,460 |
| Other Curr. Assets | $307 | $1,412 | $514 | $448 |
| Total Curr. Assets | $6,037 | $8,862 | $6,295 | $4,588 |
| Property Plant & Equip (Net) | $87 | $109 | $133 | $154 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $314 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $28 | $26 | $22 |
| Other NC Assets | $607 | $29 | $29 | $29 |
| Total NC Assets | $1,008 | $166 | $188 | $205 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,045 | $9,028 | $6,483 | $4,793 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1,346 | $1,686 | $2,208 |
| Short-Term Debt | $30 | $104 | $116 | $926 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,088 | $1,749 | $2,321 | $1,851 |
| Total Curr. Liab. | $3,119 | $3,199 | $4,123 | $4,985 |
| LT Debt | $8 | $0 | $14 | $41 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $1,116 | $20 |
| Total NC Liab. | $8 | $0 | $1,130 | $61 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $39 | $104 | $130 | $156 |
| Total Liabilities | $3,127 | $3,199 | $5,253 | $5,046 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $6 | $0 | $1,116 | $20 |
| Retained Earnings | -$86,338 | -$643,860 | -$641,230 | -$642,704 |
| AOCI | -$68 | -$109 | -$110 | -$104 |
| Other Equity | $88,931 | $649,798 | $641,454 | $642,535 |
| Total Equity | $2,530 | $5,829 | $1,230 | -$253 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $1,389 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $7,045 | $9,028 | $6,483 | $4,793 |
| Net Debt | -$5,668 | -$4,019 | -$2,385 | $274 |